Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP<sub>SWE</sub>/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology — Marcella Reale (2018) | RDL Network
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP<sub>SWE</sub>/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
Article 2018 en
Authors
MR
Marcella Reale
CD
Chiara D’Angelo
EC
Erica Costantini
Abstract
1 min read
The study demonstrates the expression profiling of pro-inflammatory cytokines and cholinergic markers as well as Aβ accumulation in OB and EC of the APPSWE/PS1dE9 Tg mice. Moreover, the study also demonstrated that the APPSWE/PS1dE9 Tg mice can be useful as a mouse model to understand the role of pro-inflammatory cytokines and cholinergic markers in pathophysiology of AD.
Harald Hampel, John Hardy, Kaj Blennow, Christopher Chen, George Perry, Seung Hyun Kim, Victor L. Villemagne, Paul Aisen, Michele Vendruscolo, Takeshi Iwatsubo, Colin L. Masters, Min Cho, Lars Lannfelt, Jeffrey L. Cummings, Andrea Vergallo
Colin Dempsey, Ana Rubio‐Araiz, Karen Bryson, Orla M. Finucane, Caroline M. Larkin, Evanna L. Mills, Avril A. B. Robertson, Matthew A. Cooper, Luke O'neill, Marina A. Lynch
Gjumrakch Aliev, Dilara Seyidova, Bruce T. Lamb, Mark E. Obrenovich, Sandra L. Siedlak, Harry V. Vinters, Robert P. Friedland, Sandra L. Siedlak, Harry V. Vinters, Robert P. Friedland, Joseph C. LaManna, Mark A. Smith, George Perry
Discussion(0)
No comments yet. Be the first to comment.